20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Big Rock Partners Acquisition Corp (NASDAQ:BRPA) shares are trading higher after the company's SPAC merger target, NeuroRx, on Monday confirmed dosing of the first patient in a Phase 3 trial of ZYESAMI was announced by the NIH last week.
The trial, designated as ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19, will study ZYESAMI to treat severely ill COVID-19 patients.
NeuroRx recently announced a plan to complete a business combination with Big Rock Partners Acquisition Corp, and intends to apply for listing on the NASDAQ under the proposed symbol 'NRXP.'
Shares of Big Rock Partners Acquisition Corp were trading 15.38% higher at $45. The stock has a 52-week low of $10.50 and a 52-week high of $76.99.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!